Forte Biosciences, Inc.
FBRXCIK 0001419041 · last filing Jul 6, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
1,625 bought / 232 sold
net +1,393 sh · −$4.9K
- buys
- 2
- sells
- 2
- insiders active
- 2
Filing tape
Filed Mon, Jul 6, 2026
- +1,152 sh · $2.1K
Wagner Paul A. — SEE REMARKS · Director
- Exercised1,250Common Stock→ 85,580 held
- Withheld for tax98Common Stock@ $21.32→ 85,482 held
- Exercised1,250Restricted Stock Units→ 2,500 held
- +241 sh · $2.9K
Riley Antony A — CHIEF FINANCIAL OFFICER
- Exercised375Common Stock→ 42,734 held
- Withheld for tax134Common Stock@ $21.32→ 42,600 held
- Exercised375Restricted Stock Units→ 750 held
Insiders on this tape
- Wagner Paul A.SEE REMARKS · Director
- Riley Antony ACHIEF FINANCIAL OFFICER
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.